发明名称 |
HEPATITIS C VIRUS INHIBITORS |
摘要 |
The present invention discloses compounds or pharmaceutically acceptable salts, esters, or prodrugs thereof, which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. |
申请公布号 |
KR20130130875(A) |
申请公布日期 |
2013.12.02 |
申请号 |
KR20137028995 |
申请日期 |
2010.03.01 |
申请人 |
ENANTA PHARMACEUTICALS, INC. |
发明人 |
QIU YAO LING;WANG CE;PENG XIAOWEN;YING LU;OR YAT SUN |
分类号 |
C07D403/14;A61K31/4178;A61P31/00 |
主分类号 |
C07D403/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|